Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,931.60
(
0.80%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
96.79
(
-4.33%
)
Bitcoin
76,764.39
(
-0.66%
)
News Focus
News Focus

Replies to post #17621 on Cytodyn Inc (CYDY)

Replies to #17621 on Cytodyn Inc (CYDY)
icon url

Northstar42

10/13/17 6:32 AM

#17622 RE: trding #17621

FDA "...can conduct an interim efficacy analysis of primary endpoint." Very good news and the key to the future IMO.
 
icon url

buckysherm

10/13/17 7:03 AM

#17628 RE: trding #17621

Who can say the FDA won't change the enrollment requirements again ? They CAN start an efficacy analysis.... will they ? I can imagine a govt worker putting this off for awhile.